Molecule Structure

Scientific Name

Docetaxel

Description of the Drug

Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01248

Brand Name(s)

Not Available

Company Owner(s)

Amneal Eu Ltd, Jiangsu Hengrui Pharmaceuticals Co Ltd, Ingenus Pharmaceuticals Llc, Pfizer Labs, Hospira Inc, Accord Healthcare Inc, Actavis Llc An Indirect Wholly-Owned Sub Of Teva Pharmaceuticals Usa Inc, Dfb Oncology Ltd, Mylan Laboratories Ltd, Hikma Farmaceutica Portugal Sa

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tubulin PROTEIN COMPLEX GROUP INHIBITOR CHEMBL2095182

Unichem Links

SureChEMBL SCHEMBL4419
PharmGKB PA449383
Human Metabolome Database HMDB0015378
DrugBank DB01248
PubChem: Thomson Pharma 14815974 14791415
PubChem 148124
Mcule MCULE-1930158681
NMRShiftDB 20165114
LINCS LSM-6360
Nikkaji J314.049K
PDBe TXL
BindingDB 36351
EPA CompTox Dashboard DTXSID0040464
DrugCentral 939
Brenda 139427
Guide to Pharmacology 6809
rxnorm DOCETAXEL DOCEFREZ TAXOTERE DOCETAXEL ANHYDROUS
PubChem: Drugs of the Future 12014196
KEGG Ligand C11231
ChEBI 4672
ZINC ZINC000085537053